Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

Blog | Care Management

HHS to provide funding for administration of COVID-19 advanced therapies in vulnerable communities

The U.S. Department of Health and Human Services announced a $150 million investment to make monoclonal antibody therapeutic treatments available for patients in vulnerable communities nationwide.

The initiative is part of an effort to promote health equity in response to the COVID-19 pandemic, HHS announced March 17.

The funding is designed to increase administration of monoclonal antibody treatments in “hard-hit communities,” according to a news release. The therapy was made available on an emergency basis by the Food and Drug Administration and has been shown to be safe and effective at preventing hospitalization and death in patients with early-stage COVID-19. The National Institutes of Health recommends the treatments for non-hospitalized COVID-19 patients who are deemed to be at high risk of developing severe disease.

“Assistance may include additional staffing, infusion center capacity in traditional and non-traditional health care settings, and equipment to administer the intravenous infusion treatments,” HHS stated. “The effort will also increase awareness among health care providers and patients about the treatment options available, including where and how to access them.”

The announcement did not include information on the process by which funding will be allocated. Distributions will be made to communities that have a high prevalence of COVID-19 and are determined to be particularly at risk based on the CDC’s social vulnerability index, which uses 15 U.S. census variables to indicate vulnerable communities.

About the Author

Nick Hut

is a senior editor with HFMA, Westchester, Ill. (

Sign up for a free guest account and get access to five free articles every month.


Related Articles | Care Management

News | Cost Effectiveness of Health

Healthcare News of Note: Medicare would save $8 billion a year if all hospitals achieved the outcomes of the most cost-efficient performers, says Lown Institute

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: America’s most cost-effective hospitals are identified, employers have boosted telemedicine and mental health benefits during the pandemic, and risk-based Medicare Advantage models gain popularity with health systems.

Q&A | Cost Effectiveness of Health

Addressing U.S. healthcare system challenges requires a focus on improving health, not just care

If we are to effectively address the huge cost challenges facing the U.S. health system, we must begin to better address the cost effectiveness of health, says Todd Nelson, HFMA’s director of professional practice and partner relationships. And it has to be through a collaborative process involving all stakeholders, he says, including not just hospitals and health systems, physicians and health plans but also patients and their communities, as well as society overall.

News | Cost Effectiveness of Health

Study shows reduction in hospital readmissions, costs for medically complex patients seen in an outpatient critical care transition clinic

In a recent study, a large group of patients with medically complex chronic conditions were referred to and seen at an Indianapolis-based outpatient critical care transition clinic saw fewer posthospital inpatient admissions and realized decreased costs of care when compared with those who were referred but did not attend the clinic. HFMA’s Shawn Stack provided insight into the importance of the study.

News | Coronavirus

Healthcare News of Note: Hospital employment continues to decline despite an increase in jobs for the healthcare sector

A continuing drop in hospital job numbers, President Biden’s plans for the ACA and how COVID-19 affected stroke care during the pandemic are all topics covered in this week’s Healthcare News of Note.